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ABSTRACT

INVESTIGATING AND MODELING POSSIBLE MECHANISMS
BY WHICH HEALTHY CELL MEMBRANES BECOME
RESISTANT TO HYDROLYSIS BY SECRETORY
PHOSPHOLIPASE A2

Jennifer Nelson
Department of Physiology and Developmental Biology
Master of Science

Secretory phospholipase A2 (sPLA2) behaves differently toward the
membranes of healthy cells compared to those of damaged or dying cells. The
enzyme catalyzes rapid and sustained hydrolysis of compromised cells
consistent with a simple catalytic mechanism. In contrast, when healthy cells are
incubated with sPLA2, they become resistant to hydrolytic attack as manifest by
three unusual observations: First, hydrolysis is transient and represents only a
small fraction of the total membrane phospholipid content. Second, subsequent

addition of sPLA2 fails to generate additional product. Third, the apparent
potency of the enzyme to cause the membrane to be refractory is much greater
than the potency for catalyzing hydrolysis. The mechanism responsible for this
resistance has not yet been identified. Using Monte Carlo and direct analytical
methods, we have developed a model capable of explaining all three of these
observations. The model requires two salient elements: only a small pool of
phospholipids in the healthy cell membrane is available for catalysis by sPLA2,
and hydrolyzed phospholipids are re‐acylated and restored very slowly to the
accessible pool. The requirement for initial hydrolysis (as opposed to the simple
physical presence of the enzyme as previously thought) was confirmed
experimentally. Additional evidence has shown that the membrane does not
remain permanently in its resistant state. Over time, the membrane resets to its
original state. The model also predicts that total substrate, reacylation rate, and
the return rate of phospholipids to the membrane should all be constant as
enzyme concentration is varied. This prediction was tested by quantitative
analysis of hydrolysis time courses at varied enzyme concentrations.
Experiments with fluorescent probes, merocyanine 540 and laurdan suggest, that
resistance may also involve physical changes to the membrane beyond the
kinetic mechanisms hypothesized in the model.
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Introduction
Secretory phospholipase A2 (sPLA2) belongs to a large family of enzymes
that catalyze the hydrolysis of phospholipids. Phospholipases have important
physiologic functions, but have also been implicated in many pathophysiologic
conditions (Vadas et al., 1993;Murakami et al., 2001). There are many different
isoforms that belong to this family of enzymes. Specifically, sPLA2 hydrolyzes
the sn‐2 acyl bond in a calcium dependent manner and produces free fatty acid
and lysophospholipid as products. sPLA2 is one of relatively few enzymes
capable of catalyzing its reaction at the interface of the cell membrane and the
extracellular fluid. Our laboratory has focused on understanding how sPLA2
interacts with the cell membrane. Ample evidence suggests that the intrinsic
properties of the membrane govern whether or not sPLA2 has access to lipid
substrate. Catalysis is preceded by two essential steps. First, the enzyme adsorbs
to the surface of the cell membrane, and second, substrate migrates from the
bilayer into the active site of the enzyme (Figure 1; Gelb et al., 1995; Berg et al.,
1997). Regulation of this second step is critical in determining the degree of
susceptibly cells exhibit towards sPLA2.
We discovered an intriguing phenomenon: sPLA2 behaves differently
toward healthy cell membranes than toward those of damaged or dying cells.
The enzyme catalyzes rapid and sustained hydrolysis of compromised cells
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consistent with a simple catalytic mechanism (Figure 2, Panel A, dashed curve;
Wilson et al., 1999; Gelb et al., 1995; Wilson et al., 1999). In contrast, when healthy
cells are incubated with sPLA2, they become resistant to hydrolytic attack as
manifest by three unusual observations. First, hydrolysis is transient and
represents only a small fraction of the total membrane phospholipid content
(Figure 2, Panel A, solid curve; (Wilson et al., 1999). The amount of product
decreases due to reacylation of species generated in the reaction. Second,
subsequent addition of sPLA2 fails to generate additional product (Figure 2,
Panel B; Wilson et al., 1999). Third, the enzyme’s apparent potency to cause the
membrane to be refractory is much greater than its potency for catalyzing
hydrolysis (Figure 2, Panel C). The mechanism responsible for this resistance has
not yet been elucidated. The first part of this project focuses on developing a
theoretical model capable of explaining resistance, and the second part tests the
model experimentally and characterizes the biophysical changes that take place
as a cell membrane becomes resistant to hydrolysis.

Materials and Methods
Reagents
Acrylodan‐labeled fatty acid‐binding protein (ADIFAB), laurdan, and
merocyanine 540 (MC540) were obtained from Invitrogen (Carlsbad, CA).
Laurdan and MC540 were suspended in dimethylsulfoxide (DMSO). ADIFAB
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was suspended in 50 mM KCl and 3 nM NaN3. Aspartate‐49 phospholipase
(APPD49 sPLA2) was purified from the venom of A. p. piscivorus using the
protocol outlined in (Maraganore et al., 1984).

Cell Culture
The cells used in all experiments were S49 mouse lymphoma cells. Cells
were maintained in a carefully controlled environment: 37° C, humidified air,
and 10% CO2 (Wilson et al., 1997).

Ca2+ and EDTA experiments
Cells were suspended in MBSS that did not contain Ca2+. The reaction
progress was monitored using ADIFAB (excitation, 390 nm; emission 432 nm and
505 nm; 65 nM final concentration; (Harris et al., 2002). EDTA, a Ca2+ chelator was
added at 150 seconds, 20 μL of 0.1 mg/mL of sPLA2 were added at 500 seconds,
and 20 μL of 3 nM Ca2+ were added at 750 seconds. In the control experiment, the
addition order of sPLA2 and Ca2+ was reversed to ascertain that the amount
added of Ca2+ was sufficient to activate sPLA2.

Two Hit Experiments
An aliquot (0.5‐4 x 106) of cells suspended in MBSS were transferred to a
cuvette and placed in the fluorometer (Fluoromax 3, Horiba Jobin‐Yvon, Edison,
NJ) and maintained at 37° C. At 100 seconds, ADIFAB was added to monitor
fatty acid production (Wilson et al., 1997). At 400 seconds, a dose of APPD49
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sPLA2 (0.02‐70 nM final concentration) was added. At 900 seconds, an additional
dose of 20 μL of 0.1 mg/mL APPD49 sPLA2 (70 nM final concentration) was
added.

Long Reversal Experiments
An aliquot (0.5‐4 x 106) of cells suspended in MBSS were transferred to a
cuvette and placed in the fluorometer and maintained at 37° C. At 100 seconds,
ADIFAB was added to monitor the reaction progress. At 400 seconds, a dose of
APPD49 sPLA2 (70 nM final concentration) was added. At 900 seconds, an
additional dose of 20 μL of 0.1 mg/mL APPD49 sPLA2 (70 nM final
concentration) was added. Cells were then transferred to a centrifuge tube,
washed, and resuspended in medium with or without serum and incubated for 0
to 24 hrs. After incubation, cells were again washed, resuspended in MBSS, and
transferred to a cuvette, and the same experimental time course was repeated.

Quantification of Experiments Using ADIFAB
Data acquired from the ADIFAB experiments were quantified by
calculation of the generalized polarization (GP): (I505 – I432)/ (I505 + I432). The GP was
then fit using a derived equation designed to model the system under study (see
section below).
To determine how much hydrolysis and resistance occurred for a
particular dose of sPLA2, the following formulas were used (Figure 3):
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Hydrolysis equaled the change in ADIFAB GP from the first dose of
sPLA2 (ΔHy) divided by the change in GP from a control dose of 70 nM, a
concentration which causes maximum hydrolysis (ΔTo).
Hydrolysis =

ΔHy
ΔTo

Resistance equaled the value one subtracted by the change in ADIFAB GP
from the second dose of sPLA2 (ΔRe) divided by the change in GP from a control
dose of 70 nM (ΔTo).
Resistance
Re
sis tan ce = 1 −

Δ Re
ΔTo

Cell Growth Curve Experiments
An aliquot (5 mL) of cells which had been suspended to come to full
density in 48 hours were treated with 50 μL sPLA2. Control cells received 50 mM
KCl and 3 mM NaN3 (solution in which sPLA2 is suspended in). Every 6 to 12
hours a 100 μL sample was taken from both the control and treatment flasks and
gently mixed with 100 μL trypan blue. The number of both viable cells and dead
cells was recorded. Data were normalized by dividing all subsequent time points
by the initial cell count. Data were plotted and fit using nonlinear regression.
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Assessment of Physical Changes that Correspond to Membrane
Resistance
Two probes were used to quantify and characterize membrane properties
of resistant cells: MC540 (excitation 540 nm, emission wavelengths recorded: 570,
585 nm), which measures interlipid spacing and laurdan (excitation 350 nm,
emission wavelengths recorded: 435, 500 nm), which measures invasion of the
bilayer surface by water molecules. Experiments were performed using a
fluorometer, which permits assessment of global changes.
Cells were harvested, washed, resuspended in 2 mL of MBSS, and
incubated with MC540, 170 nM Final, (or laurdan, 50 nM Final) at 37° C in the
fluorometer. After equilibrium was reached, a dose of sPLA2 (0.7 nM to 70 nM)
was added, and changes in the fluorescence were monitored during a time
course of 1800 seconds. The time courses generated were fitted using nonlinear
regression. For MC540, these fits allowed for determination of the maximum
change in the ratio of intensities observed at 570 and 585 nm as well as the
maximum change in the total intensity at 570 and 585 nm. For laurdan, the
maximum change in total intensities as well as maximum change in GP were
measured.
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Theory
Monte Carlo Simulations
The Monte Carlo program consists of a continuous two‐dimensional
hexagonal array capable of simulating the cell surface. Enzymes can bind to any
of the 2000 available sites provided that another enzyme is not bound to an
adjacent site (to accommodate steric hindrance). Each binding site consists of 7
phospholipids. The program is capable of varying a large number of parameters
(see Table 1), including those in the reaction scheme shown in Figure 4, and can
accommodate a second addition of enzyme. The properties of the membrane are
adjustable. A proportion of the membrane can be nonhydrolyzable (the enzyme
can bind to the site but no catalysis can occur). The affinity of the enzyme can be
different for hydrolyzable and nonhydrolyzable sites. The affinity of the enzyme
can also be orientation‐dependent; i.e. the binding depends on which part of the
enzyme surface faces the membrane. There are several ways in which an enzyme
can move to a new site on the membrane. In addition to the typical mode of
disassociation and readsorption to a new site on the membrane, the enzyme can
roll (new orientation) or scoot (same orientation) directly across the surface to a
new site. Once the properties of the membrane and enzyme have been set, the
program iterates a decision‐making routine (Figure 5), and data are generated in
the form of a time course. There are two outcomes that are reported at the end of
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each cycle: the number of enzymes molecules adsorbed to the membrane and the
amount of product.

Analytical Derivation
The distribution of phospholipids among structural states (substrate (S),
reaction product (P) and reacylated product (P*)) was modeled by the following
system of differential equations:
dP
= E B k cat ( S T − P − P * ) − k acyl P
dt

(1)

dP *
= k acyl P − k r P *
dt

(2)

ST is the total amount of substrate. kcat is the catalysis rate. kacyl is the rate of
reacylation. kr is the rate of return of reacylated lipids to the hydrolyzable pool.
The system assumes rapid equilibrium between the bound and free states
of the enzyme and was derived in terms of EB (the bound state).
EB =

ET K app
1 + ET K app

MT

(3)

ET is the total amount of enzyme. Kapp is the equilibrium constant for
enzyme adsorption and substrate migration. MT is the total amount of
membrane.
Integration of Equation 1 yields Equation 4 with the substitutions listed in
Equations 5 and 6.
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let A = E B k cat S T
P=

a=

b=

(

)

Ak r ⎛
A
b − at
a −bt ⎞
e − at − e −bt +
e +
e ⎟
⎜1 −
a−b
ab ⎝ b − a
b−a
⎠

(k r + A + k acyl ) + (k r + A + k acyl ) 2 − 4[k r ( A + k acyl ) + k acyl A]
2

(k r + A + k acyl ) − (k r + A + k acyl ) 2 − 4[k r ( A + k acyl ) + k acyl A]
2

(4)

(5)

(6)

To facilitate fitting with nonlinear regression, the data were fit with
Equation 7, a simplified version of Equation 4.
P=

(

)

A
B⎛
b − at ⎞
e − at − e −bt +
e ⎟+I
⎜1 −
ab ⎝ b − a
a−b
⎠

(7)

Theoretical Results
Monte Carlo Simulations
In simulation trials, each parameter was systematically varied to assess its
effect on the product time course. If no reacylation occurred, a typical time
course looked like Panel A Figure 6. If reacylation occurred but reacylated lipids
were available for rehydrolysis, a typical time course looked like Panel B Figure
6. In contrast, if the reacylated substrate was not available for hydrolysis, the
shape of the time course changed dramatically, and the shape depended greatly
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on the reacylation rate (Panel C Figure 6). Simulated data matched experimental
time courses best when the reacylation rate was very small (0.005). When
parameters were set to the values indicated in Table 2, the simulated product
time course exhibited a form very similar to experimental results (Figure 7).

Fitting Routine
A, a, and b were constrained based on enzyme concentration and
independent assessment of Kapp.
The value of kr was allowed to float.
Since the amount of substrate remaining at the time of the second addition
of enzyme is unknown, the value of A for the second enzyme addition (A2) was
allowed to float.
The model predicted that kr should vary randomly around a constant
value while A2 should decrease with increasing initial dose of enzyme. When
applied to actual experimental data, the parameters from the fits behaved as
expected (Figure 8). Fits of experimental data for three different enzyme
concentrations are shown in Figure 9.

Experimental Results
Resistance is Hydrolysis‐Dependent
Incubation of cells while temporarily inhibiting sPLA2 catalysis showed
that hydrolysis is required for resistance to occur. In the presence of EDTA, no
10

catalysis occurred because no free Ca2+, a necessary cofactor, was available. If
adsorption of sPLA2 alone were capable of inducing resistance by some
biophysical or biochemical means, then subsequent addition of Ca2+ would have
yielded no hydrolysis. However, when Ca2+ was added, hydrolysis occurred
(Panel B Figure 10). Positive controls were also included to ascertain that the
amount of Ca2+ added was sufficient to restore the enzyme to full catalytic
activity (Panel A Figure 10). These experiments provided evidence that
adsorption of enzyme to the surface of the cell is not enough to cause resistance.

Reversibility of Resistance
After cells had become resistant to the enzyme (exposure to 70 nM final
concentration sPLA2), they were washed and resuspended in various solutions
(MBSS, medium, and medium plus serum) and incubated at 37° C for different
periods of time (0, 1, 6, 12, and 24 hours). After the prescribed incubation time,
cells were washed and resuspended in MBSS. Another dose of sPLA2 was added
and the amount of hydrolysis was measured. If the cell membrane was still
resistant, then minimal or no hydrolysis was expected. If the cell membrane had
begun to revert to its state prior to sPLA2 exposure, then an appreciable amount
of hydrolysis was expected. Interestingly, the rate at which the membrane
reverted to its normal state (condition prior to exposure to sPLA2) depended on
what the cells were suspended in. Cells suspended in MBSS showed little or no
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reversal (Panel A Figure 11). Cells in culture medium (Panel B Figure 11) with no
serum (or with serum, not shown) showed rapid reversal.

Biophysical Changes in the Cellular Membrane
Previous experiments conducted with S49 mouse lymphoma cells
revealed pronounced changes in membrane structure that corresponded to
increased susceptibility to sPLA2 (Bailey et al., 2007). The order of lipids in the
membrane decreased and interlipid spacing increased. Similar experiments were
conducted to assess what changes, if any, occurred as the membrane became
resistant to hydrolytic attack.

Lipid Order in the Resistant Cell Membrane
Addition of sPLA2 to the cell suspension caused a rapid decrease in
apparent lipid order, as assessed by laurdan GP (Figure 12). Repetition of the
experiment at various sPLA2 concentrations demonstrated that the effect was
saturable and reproducible. The maximum change was 0.02 ± 0.01 GP units with
an EC50 value of 5.79 ± 3.48 nM sPLA2 (blue curve, Figure 12). The total intensity
of laurdan also decreased with increasing concentration of sPLA2 (maximum
change of 5% decrease, pink curve, Figure 12) with an EC50 value of 0.23 ± 0.005.

Lipid Spacing in the Resistant Cell Membrane
Interlipid spacing also changed as the membrane became resistant to
hydrolysis. The dose dependent decrease in total MC540 intensity with
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increasing concentration of sPLA2 (maximum decrease of 12%, EC50 0.71 ± 0.43)
indicated that the lipids in the cell membrane became more tightly packed
(Figure 13).

Effect of sPLA2 on Cell Growth
Over an incubation period of 48 hours with 70 nM dose of sPLA2, cell
growth appeared to be unaffected by the presence of enzyme. The doubling time
for the control cells was 10.32 ± 0.10 hours and 13.27 ± 0.37 hours for the cells
incubated with sPLA2 (Figure 14).

Discussion
It is simple to establish that cell membranes become resistant to sPLA2
(Wilson et al., 1999); however, the mechanism governing resistance needs to be
better understood. Two plausible hypotheses are easily excluded. The first
centers on the idea of rapid endocytosis of sPLA2. Sequestration of the enzyme
inside the cell would prevent hydrolysis of the outer‐leaflet; however, three
pieces of evidence refute this idea. First, a membrane that has become resistant to
hydrolysis can rapidly be rendered susceptible by the addition of ionomycin, a
calcium ionophore (Bailey et al., 2007). Thus, if the enzyme were sequestered, it
is unlikely that it would be regurgitated on the time scale of the experiment.
Second, flow cytometry data reveal that only a small percentage of the sPLA2 is
endocytosed; a large proportion is still present extracellularly and presumably
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capable of carrying out catalysis (Bailey et al., 2007). Third, a second maximum
dose of enzyme (70 nM final concentration) elicits no hydrolysis. It is difficult to
imagine a situation in which the cell could completely sequester the second dose
of enzyme before any hydrolysis occurred since it was unable to do so with the
first.
The second possible explanation for resistance centers on a receptor‐
mediated response to the presence of sPLA2. However, two pieces of evidence
suggest that this is not the case. First, if resistance depended on sPLA2 binding to
a receptor, then enzymes which do not bind to the receptor would be incapable
of causing resistance. However, experiments done by Wilson et al. (1999) showed
that bee venom sPLA2, which does not bind to sPLA2 receptor (M‐type, Ancian et
al., 1995), can cause resistance. Second, our experiments indicate that hydrolysis
is required for resistance to occur. When cells were incubated in Ca2+‐free MBSS
with sPLA2, the presence of the enzyme on the cell surface did not trigger
resistance. It was only after Ca2+ had been added back into solution and sPLA2
became active that resistance occurred. These two observations argue that the
resistance is not a receptor‐mediated response.
The next general hypothesis is whether resistance can be explained
entirely by the interactions of sPLA2 with the membrane. When we simulated the
interactions between sPLA2 and the cell membrane using a Monte Carlo
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algorithm, we identified what could potentially be the most important variables.
From the many simulations performed, two critical conclusions emerged. First,
the hydrolysis reaction must slow significantly or come to a complete stop. The
easiest way to satisfy this criterion is to limit the amount of substrate available to
the enzyme. Exhaustion of this pool would explain why the cell membrane has
become resistant. Second, the rate at which reacylated lipids are returned to the
available substrate pool must be much smaller than the rate of reincorporation of
fatty acid into phospholipids. When these two conclusions are in force, the
results of simulated time courses closely resemble experimental time courses
(Figure 15). To restate, the minimum model for resistance centers on a small,
rapidly hydrolyzable pool of lipids that upon exhaustion is slowly repopulated
over time.
A system of differential equations based on this minimum model (limited
substrate hypothesis) is capable of fitting experimental data even when
parameters are highly constrained by values determined from independent
experimental results. Parameters that were allowed to float behaved as
predicted, providing further evidence that the model could correctly provide a
mechanism for resistance.
Previous experiments published in Wilson et. al. (1999) showed that
resistance occurs even when little or no initial hydrolysis is observed
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(experiments used weakly active human group IIA and venom Lys‐49).
However, due to the high concentrations used in those experiments, the
resistance observed could be the result of competition for binding. If the
catalytically weak enzymes saturate the surface of the cells, then highly active
Asp‐49 venom sPLA2 would have diminished access to the membrane.
Additionally, these isoforms are incapable of inducing complete resistance
(Wilson et al., 1999).
Two lines of evidence suggest that resistance could be more complex than
previously thought. The first refers to the rate at which the initial naïve state of
the membrane can be restored following exposure to sPLA2. If the limited
substrate model applied, one would expect that the reversal of resistance would
involve restoration of the original pool of membrane phospholipids and that the
timing of the restoration would be fixed based on cellular metabolic processes.
Instead, the reversal rate of resistance depended on the solution in which cells
were suspended. Since the reversal rate was dependent on the type of cell
suspension, a different mechanism could be responsible for the reestablishment
of original membrane conditions.
The second reason for believing that resistance is more complex than the
limited‐substrate model is that fluorescent probes detected changes in the
membrane when cells were incubated sPLA2 . If these changes were reflective of

16

resistance, they would be small, logical with respect to susceptibility, and
dependent on sPLA2 dose in the appropriate range. As predicted, the observed
changes in membrane order (0.02 GP units and 5% maximum drop in normalized
total laurdan intensity) and interlipid spacing (12% maximum drop in
normalized MC540 intensity) were small (Figures 12 and 13). Moreover, these
changes were logical. As cell membranes become susceptible, lipid order
decreases and interlipid spacing increases which improves the ability of
phospholipids to migrate into the enzyme’s active site (Bailey et al., 2007). In
contrast, the opposite occurred as resistance emerged; cell membranes became
more ordered and interlipid spacing decreased (Figures 12 and 13).
An intriguing observation was the difference in sPLA2 potency for
inducing resistance (EC50 = 0.49) and catalyzing hydrolysis (EC50 = 3.39, Panel C
Figure 2). Although the limited‐substrate model can reconcile at least a small
difference in potency (Figure 16), a more compelling explanation relates to the
fluorescence observations. The potencies of the change in total laurdan intensity
(EC50 = 0.23) and total MC540 intensity (EC50 = 0.79) were very similar to the EC50
of resistance (0.49). Thus, since the fluorescence changes occurred at the same
range of sPLA2 dose as resistance, it is reasonable to conclude that the observed
changes in interlipid spacing correspond to resistance. Interestingly, the EC50 of
laurdan GP (5.79) was very similar to the EC50 of hydrolysis (3.39). This result
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suggests that the changes in lipid order are more closely linked to hydrolysis.
Taken together, the results encourage a hypothesis that products of hydrolysis
either directly or indirectly alter membrane structure in a way that makes it
resistant to the action of sPLA2.
How might the dose of sPLA2 be different for inducing resistance than for
hydrolysis since resistance appears to depend on the enzyme’s catalytic activity?
When a relatively small amount of available substrate has been hydrolyzed, the
reaction products generated in the membrane could be sufficient to alter the
domains where productive catalysis can occur, making subsequent hydrolysis
less favorable. For this explanation to work, the rate of domain alteration must be
slower than the rate of hydrolysis. If the rate of hydrolysis and domain alteration
equaled each other, there would be no transient burst of hydrolysis.

Conclusion
The cell membrane is a dynamic environment. The results of this study
show the delicate balance between two competing needs: first, the need to
generate product that will be used in synthesis of inflammatory molecules in a
physiological setting, and second, the need to preserve membrane integrity.
Studying how membranes become resistant to sPLA2 reveals the importance of
lipid organization in the bilayer. In this case, the properties of the membrane, not
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the enzyme, regulate the reaction. Based on the experiments performed in this
study, we conclude the following:
Monte Carlo simulations can adequately simulate the interaction of sPLA2
with the cell membrane and indicate the minimum requirements for the
resistance phenomenon.
Hydrolysis is required experimentally for resistance to occur.
Tests of the Limited Substrate Model have shown that it is capable of
explaining resistance.
Resistance is a reversible phenomenon.
Changes in total MC540 and laurdan fluorescence intensity suggest
resistance may involve physical changes in the membrane that interfere with
hydrolysis and limit the available substrate pool.
The reversibility of resistance and the physical changes in the membrane
that occur during the onset of resistance suggest that resistance may be more
complex than previously thought.
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Tables

Table 1: Monte Carlo Parameters
K1 = rate of enzyme binding
K2 = enzyme disassociation rate
Ke = probability that the lipid makes it into the
enzyme active site
Ki = rate of inhibition on hydrolysis of
occupied, non‐hydrolysable sites.
Kacyl = rate of reacylation
Orientation effect = binding strength is
altered by some factor if the enzyme active‐
site is down.
# non hydrolysable sites = establishes x/2000
sites are unavailable for hydrolysis
Ratio of affinity for non‐hydrolysable sites =
enzyme affinity for non‐hydrolysable sites can
multiplied by some factor
T = length of experiment
Initial enzyme concentration
Determines how much additional enzyme
will be added at a time point
When will the additional enzyme be added?
Reacylation dependent on binding = the
reacylation rate can increase every time an
enzyme binds to a lipid
Reacylation dependent on hydrolysis =
reacylation rate can increase every time a lipid
is hydrolyzed.
Reacylated lipids may become unavailable for
hydrolysis once they have been reacylated,
they become labeled as non‐hydrolysable
sites.
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Table 2: Parameters Values Used to Generate Figure 19A
Parameter

Value

K1

0.5

K2

0.5

ke

0.5

kacyl

0.005

Experiment length

2500

Initial dose of enzyme
Second dose of
enzyme
Time of second dose
addition
Lipids available for
rehydrolysis

50 to 600
600
1750
No
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Figures
Figure Legends
Figure 1: Reaction Scheme of sPLA2 with a Membrane E: sPLA2, EB: sPLA2
adsorbed to membrane surface, S: substrate, EBS: sPLA2 absorbed to membrane
and with substrate bound in the active site, P: hydrolysis product
(lysophospholipid and fatty acid), K1: equilibrium constant for adsorption, K2:
equilibrium constant for substrate migration, kcat: rate of catalysis.
Figure 2: Panel A S49 cells were incubated with 5 uL of ionomycin or DMSO, 20
μL of sPLA2 was added, and the amount of reaction product generated was
measured over time using ADIFAB. Panel B This figure shows the result of a
typical ʺtwo hit” experiment. At the gray arrow 20 μL of sPLA2 was added. After
a new baseline had been established, a second 20 μL dose of sPLA2 was added
as indicated by the black arrow. Panel C Analysis of a series of “two hit”
experiments. The results of the analysis were fit using non‐linear regression. The
dashed curve is the resistant curve and the solid curve is the hydrolysis curve.
Figure 3: Method Used to Calculate Resistance and Total Hydrolysis
Hydrolysis equaled the change in ADIFAB GP from the first dose of sPLA2
(ΔHy) divided by the change in GP from a control dose of 70 nM, a concentration
which causes maximum hydrolysis (ΔTo). Resistance equaled the value one
subtracted by the change in ADIFAB GP from the second dose of sPLA2 (ΔRe)
divided by the change in GP from a control dose of 70 nM (ΔTo).
Figure 4: Expanded Reaction Scheme of sPLA2 with a Membrane E: sPLA2, EB:
sPLA2 adsorbed to membrane surface, S: substrate, EBS: sPLA2 absorbed to
membrane and with substrate bound in active the site, P: hydrolysis product
(lysophospholipid and fatty acid), K1: equilibrium constant for adsorption, K2:
equilibrium constant for substrate migration, kcat: rate of catalysis, kacyl: rate of
reacylation, kr: rate of return of reacylated lipids to the membrane.
Figure 5: Flow Chart of the Algorithm Executed by the Monte Carlo
Simulation
Figure 6: Simulated Time Courses: Panel A Example of a typical time course
when the reacylation rate (kacyl) is set to zero. Panel B Example of a typical time
course when the reacylation is a small number (0.005) and lipids are available for
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rehydrolysis. Panel C Example of a typical time course when reacylation is a
small number (0.005) and lipids are not available for rehydrolysis.
Figure 7: Simulated Time Course: Variation of Initial Enzyme Dose Initial
enzyme concentration varied between 50 and 600, kacyl equaled 0.005, and lipids
were not available for rehydrolysis.
Figure 8: Results of Fitting Double Dose Experiments with Equation 7 Green
curve: parameters A2 (reflects amount of substrate left at time of second addition
of enzyme) and purple curve: kr (reflects reacylation rate).
Figure 9: Examples of Fitting “Two Hit” Experiments with Equation 7 A, a, and
b were constrained based on enzyme concentration and independent assessment
of Kapp. The value of kr was allowed to float. Since the amount of substrate
remaining at the time of the second addition of enzyme is unknown, the value of
A for the second enzyme addition (A2) was allowed to float. Fits for three
different experiments are shown (70.0 nM, 0.2 nM, 0.7 nM).
Figure 10: Results of Ca2+ and EDTA experiments Cells were suspended in
MBSS that did not contain Ca2+. Panel A EDTA was added at 150 seconds, 20 μL
of 3 nM Ca2+ was added at 500 seconds, and 20 μL of 0.1 mg/mL of sPLA2 was
added 750 seconds. Panel B EDTA was added at 150 seconds, 20 μL of 0.1
mg/mL of sPLA2 was added at 500 seconds, and 20 μL of 3 nM Ca2+ were added
at 750 seconds.
Figure 11: Reversal of Resistance: Cells Incubated in MBSS and Medium Panel
A Amount of initial hydrolysis (black curve), amount of hydrolysis after
incubation 15 minute incubation in MBSS (purple curve). Panel B Amount of
initial hydrolysis (as measured by change in ADIFAB GP, black curve), amount
of hydrolysis after incubation in medium (as measured by change in ADIFAB
GP, purple curve).
Figure 12: Change of Laurdan Fluorescent Intensity and GP as a Function of
SPLA2 Concentration Cells were suspended in MBSS. After equilibrium was
reached, a dose of sPLA2 (0.7 nm to 70 nM) was added and changes in the
laurdan fluorescence were monitored during a time course of 1800 seconds. The
maximum change in the intensities (blue curve) and GP (pink curve) were
calculated.
Figure 13: Change of MC540 Fluorescent Intensity Cells were suspended in
MBSS. After equilibrium of the probe was reached, a dose of sPLA2 (0.7 nm to 70
nM) was added and changes in the fluorescence were monitored during a time
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course of 1800 seconds. The maximum change in MC540 total intensity (blue
curve) was calculated.
Figure 14: Cell Growth is Not Affected by sPLA2 The growth of cells was with
and without sPLA2. The growth of control cells is reported in the black curve and
the growth of cells treated with 70nM (final concentration) sPLA2 is reported in
the green curve.
Figure 15: Comparison of Simulated Double Dose Experiments to Actual
Double Dose Experiments Panel A Results of Monte Carlo simulations in which
the initial dose of enzyme was varied (50 to 600). The second dose of enzyme
(600) was added at 1750. Panel B Results of actual double dose experiments in
which the initial dose of enzyme was varied (0.02 to 70 nM). The second dose of
enzyme (70 nM) was added at 600 seconds.
Figure 16: Comparison of Potencies Generated from Simulated “Two Hit”
Experiments The amount of resistance and hydrolysis caused by a particular
dose of sPLA2 in the simulated experiments from Panel B Figure 15 was
calculated using the method described in Figure 3. The results of the analysis
were fit using non‐linear regression. The green curve is the resistant curve and
the black curve is the hydrolysis curve.
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